WASHINGTON, March 26, 2018 -- The National Business Group on Health, a non-profit association of more than 420 large, U.S. employers, today announced it has elected two corporate human resources executives, James Huffman and Tracey Stephens, to its board of directors, effective immediately.
“We are delighted to welcome Jim and Tracey to our Board of Directors to help frame how the Business Group and our members can advance improvements in health care delivery and payment reform and how to best deploy the healthiest and most productive workforce possible,” said Brian Marcotte, NBGH President and CEO. “They bring a wealth of experience and insight in health care and human resources, and we are fortunate to add representation of their caliber to our board.”
James Huffman is senior vice president, head of employee benefits for Bank of America. In this role, he is responsible for the design and delivery of employee benefits for Bank of America’s workforce. This includes programs and services for employee health & wellness, retirement savings, and life management. Huffman works closely with senior management to set the overall strategic approach for the company’s benefits, and oversees the company’s benefits innovation, product and plan design, benefits delivery, benchmarking and measurement.
Tracey Stephens is vice president of global benefits for Dell. Since joining Dell in 2013, she led a complete redesign of Dell’s U.S. benefits and expanded Dell’s employee well-being initiative. During Stephens’ tenure, Dell has been recognized multiple times as a great place to work, and the company’s benefits programs are often cited as an integral component of this recognition.
“Jim and Tracey bring an outstanding mix of business experience to the board,” said Judith Verhave, Chairman of the Board of the National Business Group on Health. “Our members continue to look for innovative and forward-thinking approaches to solving the health care cost crisis. Their guidance and expertise will further enhance the Business Group’s ability to support our members.”
About the National Business Group on Health®
The National Business Group on Health is the nation's only non-profit organization devoted exclusively to representing large employers' perspective on national health policy issues and helping companies optimize business performance through health improvement, innovation and health care management. The Business Group’s mission is to keep its membership on the leading edge of innovation, thinking and action to address health care cost and the delivery, financing, affordability and consumer experience with the health care system. Business Group members, which include 72 Fortune 100 companies, provide health coverage for more than 50 million U.S. workers, retirees and their families. For more information, visit www.businessgrouphealth.org.
Contact:
Ed Emerman
609-275-5162
[email protected]


Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Apple Restores Telegram to App Store After Content Policy Violation
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Jetstar to Charge for Overhead Cabin Bags From February
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook 



